论文部分内容阅读
目的:观察细辛脑联合喘可治注射液治疗慢性阻塞性肺疾病的临床疗效。方法:将80例慢性阻塞性肺疾病患者随机分为治疗组与对照组,均予常规治疗,治疗组在常规治疗的基础上给予细辛脑联合喘可治注射液治疗。结果:治疗组总有效率明显高于对照组,症状、体征改善时间短于对照组,差异具有统计学意义(P<0.05)。结论:细辛脑联合喘可治注射液治疗慢性阻塞性肺疾病有较好的疗效。
Objective: To observe the clinical effect of Asarum combined with Chuankezhi injection on chronic obstructive pulmonary disease. Methods: Eighty patients with chronic obstructive pulmonary disease were randomly divided into treatment group and control group, and were given routine treatment. The treatment group was given Asarum combined with Chuankezhi injection on the basis of routine treatment. Results: The total effective rate of the treatment group was significantly higher than that of the control group, and the improvement time of symptoms and signs was shorter than that of the control group (P <0.05). Conclusion: Asarone combined with Chuankezhi injection has good curative effect on chronic obstructive pulmonary disease.